Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer-associated retinopathy.

C E Thirkill, A M Roth, J L Keltner

    Archives of Ophthalmology (Chicago, Ill. : 1960)
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Researchers identified antiretina antibodies in cancer patients with vision loss, targeting a specific 23,000-dalton CAR antigen. This discovery could aid in early detection of cancer-associated retinopathy (CAR) syndrome.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Paraneoplastic vitelliform retinopathy secondary to metastatic melanoma.

    Klinische Monatsblatter fur Augenheilkunde·2015
    Same author

    Expanding sexually transmitted infection screening among women and men engaging in transactional sex: the feasibility of field-based self-collection.

    International journal of STD & AIDS·2013
    Same author

    Herpes simplex virus type 2 serological testing at a community court: predictors of test acceptance and seropositivity among female defendants.

    International journal of STD & AIDS·2013
    Same author

    An unusual case of melanoma-associated retinopathy.

    Ocular immunology and inflammation·2012
    Same author

    Low acceptance of HSV-2 testing among high-risk women.

    International journal of STD & AIDS·2011
    Same author

    Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies.

    Eye (London, England)·2011
    Same journal

    The economics of the initial preventive physical examination in medicare-reply.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    December 2011 archives web quiz winner.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    About this journal.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    Same journal

    In memoriam: goodwin m. Breinin, MD (1918-2011).

    Archives of ophthalmology (Chicago, Ill. : 1960)·2013
    See all related articles

    Area of Science:

    • Ophthalmology
    • Oncology
    • Immunology

    Background:

    • Cancer-associated retinopathy (CAR) syndrome is a rare autoimmune condition.
    • It presents with vision loss in patients with underlying malignancies.

    Observation:

    • Four cancer patients with vision loss showed antiretina antibodies in their serum.
    • These antibodies bound to a 23,000-dalton antigen in normal retinal tissue, termed the CAR antigen.

    Findings:

    • Antibodies against the CAR antigen were specific to patients with cancer and vision loss.
    • No such antibodies were detected in cancer patients without vision loss, retinitis pigmentosa patients, or healthy individuals.

    Implications:

    • Early detection of rising antibody titers against the CAR antigen may help identify patients at risk for CAR syndrome.

    Related Experiment Videos

  • This finding could lead to earlier diagnosis and intervention for cancer-associated retinopathy.
  • Understanding the CAR antigen is crucial for diagnosing and potentially treating this paraneoplastic syndrome.